XML 25 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash flows from operating activities:    
Net income $ 48,499 $ 8,942
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization, net 10,691 9,196
Provision for deferred income taxes 550 168
Net realized gains on investments (1,226) (2,702)
Changes in assets and liabilities:    
Accounts receivable (26,190) (18,477)
Accrued investment income 77 851
Receivable from reinsurers (5,577) (3,285)
Ceded unearned premiums (990) (173)
Deferred policy acquisition costs (7,189) (6,683)
Other assets 1,835 1,746
Loss and loss adjustment expense reserves 9,769 (6,054)
Unearned premium reserves 41,875 39,112
Accounts payable and accrued liabilities (3,312) (15,267)
Payable to reinsurers 9,539 5,393
Other liabilities (1,951) 7,704
Net cash provided by operating activities 76,400 20,471
Cash flows from investing activities:    
Fixed maturities purchased (234,335) (260,405)
Equity securities purchased (8,343) (12,512)
Proceeds from sales and paydowns of fixed maturities 132,576 200,728
Proceeds from maturities, redemptions, and calls of fixed maturities 48,014 74,162
Proceed from sales of equity securities 7,939 6,235
Fixed assets purchased (2,987) (2,828)
Net cash (used for) provided by investing activities (57,136) 5,380
Cash flows from financing activities:    
Proceeds from stock options exercised 1,028 900
Excess tax expense from stock options exercised (44) (4)
Dividends paid to shareholders (24,441) (22,729)
Acquisition of treasury stock 0 (43)
Net cash used for financing activities (23,457) (21,876)
Net (decrease) increase in cash and cash equivalents (4,193) 3,975
Cash and cash equivalents at beginning of year 37,890 40,291
Cash and cash equivalents at end of period $ 33,697 $ 44,266